Skip to main content
Logo
European Innovation Council
  • private sector

Resistell

Rapid diagnostic for bacterial SEPSIS and AMR urgently needed for ICU patients in COVID-19-like epidemics

Resistell AG logo

Overview

Description

Developer of an antibiotic susceptibility device designed to offer an alternative to a culture-based antibiogram. The company's device is based on the detection of movement caused by living bacterial cells to determine bacterial resistance to antibiotics, enabling patients to have proper antibiotics on time.

Website
Country
  • Switzerland
Sector
  • Medical Technologies